Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Vector Science and Therapeutics Current Ratio?
Vector Science and TherapeuticsTSXV:PAIN -4.32%14 Current Ratio is 20.79 as of Feb. 2026, which is 76% above its 10-year median of 11.82. GuruFocus rates TSXV:PAIN with a GF Score™ of 14/100. Among 853 Medical Devices & Instruments companies, Vector Science and Therapeutics ranks better than 98.12% on this metric.
Vector Science and Therapeutics has a current ratio of 20.79. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Vector Science and Therapeutics's Current Ratio or its related term are showing as below:
TSXV:PAIN'
s Current Ratio Range Over the Past 10 Years
Min: 7.16 Med: 11.82 Max: 20.79
Current: 20.79
During the past 2 years, Vector Science and Therapeutics's highest Current Ratio was 20.79. The lowest was 7.16. And the median was 11.82.
TSXV:PAIN's Current Ratio is ranked better than 98.12% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs TSXV:PAIN: 20.79
Vector Science and Therapeutics (TSXV:PAIN) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Vector Science and Therapeutics Current Ratio Related Terms
Vector Science and Therapeutics Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vector Science and Therapeutics Current Ratio Chart
Vector Science and Therapeutics Annual Data
Trend
Aug24
Aug25
Current Ratio
0.00
11.82
Vector Science and Therapeutics Quarterly Data
Aug24
Nov24
Aug25
Nov25
Feb26
Current Ratio
0.00
0.00
11.82
7.16
20.79
TSXV:PAIN vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Vector Science and Therapeutics's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vector Science and Therapeutics Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vector Science and Therapeutics's Current Ratio distribution charts can be found below:
* The bar in red indicates where Vector Science and Therapeutics's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vector Science and Therapeutics (TSXV:PAIN) has a Current Ratio of 20.79 as of Feb. 2026. This is 76% above median its historical median of 11.82. Over the past decade, Vector Science and Therapeutics' Current Ratio has ranged from 7.16 to 20.79. According to the industry distribution chart, Vector Science and Therapeutics ranks #16 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Vector Science and Therapeutics' Current Ratio too high?
Vector Science and Therapeutics' current Current Ratio of 20.79 is 76% above median its 10-year median of 11.82. Over the past 10 years, this metric has ranged from a low of 7.16 to a high of 20.79. The Medical Devices & Instruments industry median Current Ratio is 2.49. Vector Science and Therapeutics' value of 20.79 is 734.9% above this industry median. Based on the distribution chart, Vector Science and Therapeutics ranks #16 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vector Science and Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vector Science and Therapeutics' Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vector Science and Therapeutics ranks #16 out of 853 companies for Current Ratio. This places Vector Science and Therapeutics in the top 2% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.49. Vector Science and Therapeutics' value of 20.79 is 734.9% above this benchmark. Historically, Vector Science and Therapeutics' own Current Ratio has ranged from 7.16 to 20.79 over the past decade. While the company's 10-year median is 11.82 vs. the industry median of 2.49, Vector Science and Therapeutics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vector Science and Therapeutics's current Current Ratio of 20.79 is 734.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vector Science and Therapeutics's current Current Ratio is 20.79, which is 76% above median its own 10-year median of 11.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vector Science and Therapeutics stock overvalued right now?
Vector Science and Therapeutics (TSXV:PAIN) has a current Current Ratio of 20.79. The current Current Ratio is 20.79, which is 76% above median its 10-year median of 11.82 and 734.9% above the Medical Devices & Instruments industry median of 2.49. Vector Science and Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Vector Science and Therapeutics (TSXV:PAIN), the current Current Ratio is 20.79 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vector Science and Therapeutics Business Description
Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
14GF Score
Get the complete analysis for TSXV:PAIN
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PAIN has been successfully added to your 
